Large Cap Archives - Page 177 of 437

2 minute read

Moderna Struggles With Weaker COVID-19 Vaccine Demand, Expects To Return To Growth In 2025, Stock Plunges

November 2, 9:33 AM

Moderna Inc (NASDAQ: MRNA) shares are trading lower after the company reported a deeper Q3 loss of $(9.53), down from EPS income of $2.53.

MRNA

1 minute read

Analyst Sees Over €10B Annual FCF For Stellantis, Despite Forecasting Lower Earnings In FY24-25

By Lekha Gupta

November 1, 3:42 PM

Bernstein analyst Daniel Roeska upgraded Stellantis N.V. (NYSE: STLA) to Outperform from Market-Perform at an increased price target of

STLA

1 minute read

Merck’s Blockbuster Cancer Drug Keytruda Secures FDA Approval For Biliary Tract Cancer

By Vandana Singh

November 1, 1:51 PM

The FDA approved Merck & Co Inc's (NYSE: MRK) Keytruda, in combination with gemcitabine and cisplatin, for locally advanced unresectable or

MRK

1 minute read

Healthcare Analytics Solutions Provider IQVIA Cuts Annual Forecast, Sees Demand Slowing For Services

By Vandana Singh

November 1, 1:47 PM

IQVIA Holdings Inc (NYSE: IQV) reported Q3 sales of $3.74 billion, up 4.9% Y/Y on a reported basis and 4.1% at constant currency (CC),

IQV

2 minute read

Legal Woes Mount for Bayer As Roundup Weed Killer-Related Cancer Cases Continue, Faces Third Trial Loss

By Vandana Singh

November 1, 1:31 PM

Bayer AG (OTC: BAYRY) (OTC:

BAYRY

1 minute read

Why Is Cancer Player Cellectis Stock Trading Over 100% Higher Today?

By Vandana Singh

November 1, 1:20 PM

Cellectis SA (NASDAQ: CLLS) shares are trading higher after the company

AZN

1 minute read

Is There An Opportunity To Buy IDEXX Labs, The Animal Diagnostics-Focused Firm Stock After Q3 Performance? Analyst Answers

By Vandana Singh

November 1, 12:32 PM

IDEXX Laboratories Inc (NASDAQ: IDXX) reported Q3 FY23 sales of $915.53 million, missing the consensus of $926.76 million

IDXX

1 minute read

Insurance Firm Humana Shares Fall After Q3 Performance – Here’s Why

By Vandana Singh

November 1, 12:23 PM

Humana Inc (NYSE: HUM) reported Q3 adjusted EPS of $7.78 compared to $7.31 a year ago, beating the consensus of $7.16.

HUM

2 minute read

Thermo King Maker Trane Technologies’ Shares Are Surging: Here’s Why

By Lekha Gupta

November 1, 10:02 AM

Trane Technologies PLC (NYSE: TT) shares are trading higher by around 9% after the company reported

2 minute read

GSK Lifts Annual Guidance Again Helped By Strong Launch Of RSV Vaccine, Steady Demand For Shingles Shot

By Vandana Singh

November 1, 8:25 AM

GSK plc (NYSE: GSK) reported Q3 FY23 s

GSK